Bellevue, WA (April 10, 2007)

Clarisonic® Brushes Up with New Financing and Noteworthy Additions to the Board of Directors

Pacific Bioscience Laboratories Inc. (PBL), maker of the CLARISONIC Skin Care Brush, is pleased to announce two new members to their Board of Directors, Jane McKellar and Joel Kanter.

Jane McKellar is CEO of Stila Corporation, a global prestige cosmetics company that was purchased in early 2006 from the Estee Lauder Group. Jane was a senior executive with Elizabeth Arden, including extensive experience in international business development. With a proven record of success in the consumer goods sector and a breadth of experience in the beauty and internet portal industries, Ms. McKellar will serve as a valued addition to the Clarisonic family.

Joel Kanter is President of Windy City, Inc., a privately held investment firm. Mr. Kanter has broad experience working in the business, legal and political realms and currently serves on the Board of Directors of several public companies. Mr. Kanter also sits on the boards of several independent schools and universities.

In continuation of the company’s strong momentum and proven traction amongst consumers and investors alike, PBL announces closing on a $10.5 private equity placement. The equity placement is comprised of qualified angel investors and a major investment by Rosewood Capital, a San Francisco private equity firm, which is focused exclusively on equity investments in the consumer growth sector, with over $600 million under management. Rosewood’s portfolio includes leaders in many different sectors of the consumer economy, including marketers of innovative sports apparel (Under Armour), retailers serving emerging population groups (Anna’s Linens), marketing and financial services providers (QuinStreet, CapitalSource, Offit Hall Capital Management, Republic Federal Bank) and leading national restaurant concepts (Carino’s Italian Grill, Jamba Juice, Noah's Bagels and Rubio’s Fresh Mexican Grill).

Blythe Jack, Managing Director of Rosewood Capital states, “We love consumer product companies with breakthrough products and strong experienced management. Clarisonic is a natural fit for us, and we’re very excited about being part of their future success.”

The new financing will be allocated to fund expansion plans, accelerating Clarisonic’s rollout in the marketplace and developing some new and exciting products. David Giuliani, CEO of Clarisonic explains, “We’re gratified with how consumers and skin care professionals alike tell us that Clarisonic serves a real need for both health and beauty. Rosewood is a partner with significant consumer product expertise that can help PBL fulfill Clarisonic’s potential. Clarisonic can exceed even Sonicare in terms of high growth rates.”

About Pacific Bioscience Laboratories

Pacific Bioscience Laboratories Inc. is a leading innovator in sonic skin care and the creator of the Clarisonic Skin Cleansing System, the first professional-caliber sonic skin care system for healthy, younger-looking skin and the cleansing standard of renowned spas, leading dermatologists and beauty retailers nationwide. The encore innovation from the primary inventor of Sonicare®, Clarisonic represents Pacific Bioscience Laboratories’ ongoing mission to develop and market technically advanced and clinically proven products that make a clear difference in skin care. Clarisonic is distributed through dermatologists, cosmetic surgeons, spas and prestige retailers such as Sephora, Nordstrom, Saks Fifth Avenue, Ulta, Beauty.com and SkinStore.com. Clarisonic has been acknowledged as a beauty award winner by Women’s Health magazine and by retailers QVC and Sephora. For more information, visit the Clarisonic website.

Press Office

, or at Behrman Communications: (212) 986-7000.